Prediction of relative potency of ketone protease inhibitors using molecular orbital theory

Bioorganic and Medicinal Chemistry

Volumn 4, Issue 10, 1996, Pages 1673-1677

  Chan, A W Edith ^a,b   Golec, Julian M C ^a  

^a Hoechst Marion Roussel   (United Kingdom)

^b Selectide Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KETONE; PROTEINASE INHIBITOR;

ARTICLE; CALCULATION; CHEMICAL BOND; CHEMICAL STRUCTURE; DRUG POTENCY; ENERGY; PREDICTION; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

EID: 0030272270     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/0968-0896(96)00189-7     Document Type: Article

References (33)

1. 1. (a) Wiley, R. A.; Rich, D. H. Med. Chem Rev. 1993, 13, 327.
2. (b) Jakubowski, J. A.; Smith, G. F.; Sall, D. J. Annu. Rep. Med. Chem. 1992, 27, 99.
3. (c) Stone, S. R. Trends Cardiovas. Med. 1995, 5, 134.
4. 2. (a) Edwards, P. D.; Bernstein, P. R. Med. Res. Rev. 1994, 14, 127 and refs therein.
5. (b) Stein, R. A.; Strimpler, A. M.; Edwards, P. D.; Lewis, J. J.; Manger, R. C.; Schwartz, J. A.; Stein, M. M.; Trainor D. A.; Wildonger, R. A.; Zottola, M. A. Biochemistry 1987, 26, 2682.
6. 3. (a) Black, R. A.; Kronheim, S. R.; Sleath, P. R. FEBS Lett. 1989, 247, 386.
7. (b) Kostura, M. J.; Tocci, M. J.; Limjuco, G.; Chin, J.; Cameron, P.; Hillman, A. G.; Chartrain, N. A.; Schmidt, J. A. Proc. Natl. Acad. Sci. U.S.A. 1989, 86, 5227.
8. (c) Dolle, R. E.; Hoyer, D.; Prasad, C. V. C; Schmidt, S. J.; Helaszek, C. T.; Miller, R. E.; Ator, M. A. J. Med. Chem. 1994, 37, 563.
9. (d) Kroemer, G.; Petit, P.; Zamzami, N.; Vayssiere, J.-L.; Mignotte, B. FASEB J. 1995, 9, 1277.
10. (e) Kumar, S.; Harvey, N. L. FEBS Lett. 1995, 375, 169.
11. 4. Mehdi, S. Bioorg. Chem. 1993, 21, 249 and refs therein.
12. 5. Edwards, P. D.; Meyer, Jr E. F.; Vijayalakshmi, J.; Tuthill, P. A.; Andisik, D. A.; Gomes, B.; Strimpler, A. J. Am. Chem. Soc. 1992, 114, 1854.
13. 6. (a) Edwards, P. D.; Wolanin, D. J.; Andisik, D. A.; Davis, M. W. J. Med. Chem. 1995, 38, 76.
14. (b) Edwards, P. D.; Zottola, M. A.; Davis, M.; Williams, J.; Tuthill, P. A. J. Med. Chem. 1995, 38, 3972.
15. 7. Tsutsumi, S.; Okonogi, T.; Shibahara, S.; Ohuchi, S.; Hatsushiba, E.; Patchett, A. A.; Christensen, B. G. J. Med. Chem. 1994, 37, 3492.
16. 8. Taylor, P. J.; Wait, A. R. J. Chem. Soc. Perkin. Trans. 2 1986, 1765.
17. 9. (a) Bürgi, H.-B.; Dunitz, J. D.; Shefter, E. J. J. Am. Chem. Soc. 1973, 95, 5065; Acta Crystallogr., Sect. B 1974, 30B, 1517.
18. 9. (a) Bürgi, H.-B.; Dunitz, J. D.; Shefter, E. J. J. Am. Chem. Soc. 1973, 95, 5065; Acta Crystallogr., Sect. B 1974, 30B, 1517.
19. (b) Bürgi, H.-B.; Lehn, J. M.; Wipff, G. J. Am. Chem. Soc. 1974, 96, 1956.
20. (c) Bürgi, H.-B.; Dunitz, J. D.; Lehn, J. M.; Wipf, G. Tetrahedron 1974, 30, 1563.
21. (d) Minato, T.; Fujimoto, H.; Fukui, K. Bull. Chem. Soc. Jpn 1978, 51, 1621.
22. (e) Eisenstein, O.; Hoffmann, R. J. Am. Chem. Soc. 1981, 103, 4308.
23. 10. Albright, T. A.; Burdett, J. K., Whangbo, M. H. In Orbital Interactions in Chemistry; Wiley-Interscience, 1985; Chapter 3, 10.5, and refs therein
24. 11. Abraham, M. H.; Duce, P. P.; Prior, D. V.; Barratt, D. G.; Morris, J. J.; Taylor, P. J. J. Chem. Soc., Perkin Trans. 2 1989, 1355.
25. 12. Spartan 3.0 program running on a Indigo II workstation; distributed by Wavefunction, Inc., Irvine, CA 92715, U.S.A.
26. 13. (a) Binkley, J. S.; Pople, J. A.; Hehre, W. J. J. Am. Chem. Soc. 1980, 102, 939.
27. (b) Gorden, M. S.; Binkley, J. S.; Pople, J. A.; Pietro, W. J.; Hehre, W. J. J. Am. Chem. Soc. 1982, 104, 2797.
28. (c) Pietro, W. J.; Francl, M. M.; Hehre, W. J.; De Frees, D. J.; Pople, J. A.; Binkley, J. S. J. Am. Chem. Soc. 1982, 104, 5039.
29. (d) Dobbs, K. D.; Hehre, W. J. J. Comput. Chem. 1986, 7, 359.
30. 14. (a) Hehre, W. J.; Ditchfield, R.; Pople, J. A. J. Chem. Phys. 1972, 56, 2257.
31. (b) Hariharan, P. C.; Pople, J. A. Chem. Phys. Lett. 1972, 16, 217.
32. (c) Francl, M. M.; Pietro, W. J.; Hehre, W. J.; Binkley, J. S.; Gorden, M. S.; De Frees, D. J.; Pople, J. A. J. Chem. Phys. 1982, 77, 3654.
33. 15. TSAR program from Oxford Molecular.